Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL29349602 | 1.00 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL162699 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL29588079 | 1.00 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL31567892 | 1.00 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL8744243 | 1.00 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL9398109 | 1.00 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL9634300 | 1.00 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL30062427 | 1.00 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL8934854 | 1.00 | CA2 (0.50) | — | |
| Phosphoric Acid SCHEMBL9395842 | 1.00 | CA2 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 644 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144915-A1 | Biomimetic Vascularized 3D Reinforced PCL/Collagen/In-Situ HAPclay Scaffolds With Iliotibial Band Cavity for Anterior Cruciate Ligament (ACL) Regeneration | SANFORD HEALTH (US) | 2026-05-28 | — | — | US | claimed |
| EP-3834855-B1 | PRE-MIXED STRONTIUM SILICATE-BASED BIOLOGICAL HYDRAULIC CEMENTING PASTE COMPOSITION, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | BEIJING C ROOT DENTAL MEDICAL DEVICES CO LTD (CN) | 2026-05-13 | — | — | EP | claimed |
| EP-3402443-B1 | DEVICES AND COMPOSITIONS AND METHODS OF USE THEREOF | REVBIO INC (US) | 2026-05-06 | — | — | EP | claimed |
| US-20260114749-A1 | Infused Particles | VIVEX BIOLOGICS GROUP INC (US) | 2026-04-30 | — | — | US | claimed |
| US-20260108431-A1 | BIOACTIVE COMPOSITES FOR BONE VOID FILLER COMPOSITIONS AND METHODS | ORTHOMOD LLC (US) | 2026-04-23 | — | — | US | claimed |
| EP-3200748-B2 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS | POLYPID LTD (IL) | 2026-04-15 | — | — | EP | claimed |
| US-20260070967-A1 | AFFIBODY-BASED DUAL AFFINITY FUSION PROTEINS AND USES THEREOF | UNIVERSITY OF OREGON (US) | 2026-03-12 | — | — | US | claimed |
| EP-4512436-B1 | BONE GRAFT COMPOSITION BASED ON GLUCURONIC ACID-1-PHOSPHATE | DENTSPLY SIRONA INC (US) | 2026-03-04 | — | — | EP | claimed |
| US-20260014404-A1 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | PERIMETER SOLUTIONS, LP (US) | 2026-01-15 | — | — | US | claimed |
| EP-4504146-B1 | ALKALINE INTRAORAL FORMULATIONS | EMPLICURE AB PUBL (SE) | 2025-12-17 | — | — | EP | claimed |
| WO-2022152347-A1 | DENTAL CARE PRODUCT | DR. KURT WOLFF GMBH & CO. KG (DE) | 2022-07-21 | — | — | WO | claimed |
| WO-2022140954-A1 | BIODEGRADABLE AND INJECTABLE BONE COMPOSITE AND USES THEREOF | BRILLIANCE BIOMEDICINE CO., LTD. (CN) | 2022-07-07 | — | — | WO | claimed |
| EP-4017506-A1 | HEMOSTATIC DEVICE AND METHOD | Joy Medical Devices Corporation (TW) | 2022-06-29 | — | — | EP | claimed |
| US-20220194849-A1 | COMPOSITIONS AND METHODS FOR ADHESION TO SURFACES | REVBIO INC (US) | 2022-06-23 | — | — | US | claimed |
| EP-3325030-B1 | BONE GRAFT SYSTEM | UCL BUSINESS LTD (GB) | 2022-06-01 | — | — | EP | claimed |
| CN-114555098-A | Hemostatic devices and methods | 喜乐医疗器材股份有限公司 | 2022-05-27 | — | — | CN | claimed |
| EP-3999136-A1 | BONE CEMENT WITH HYALURONIC ACID | Graftys (BE) | 2022-05-25 | — | — | EP | claimed |
| EP-2968084-B1 | COMPOSITIONS FOR TREATMENT OF XEROSTOMIA AND FOR TOOTH TREATMENT | 3 IN 1 DENTAL PLLC (US) | 2022-04-13 | — | — | EP | claimed |
| US-20220096712-A1 | BIOMATERIALS COMPRISING A SCAFFOLD CONTAINING A MINERAL COMPOUND, AND USES THEREOF AS BONE SUBSTITUTES | UNIVERSITE DE STRASBOURG (FR) | 2022-03-31 | — | — | US | claimed |
| US-11241515-B2 | Controlled production of spherical calcium phosphate, magnesium phosphate, and strontium phosphate particles for dental and orthopedic applications using dual asymmetric centrifugation | OSTEONOVUS LLC (US) | 2022-02-08 | — | — | US | claimed |